The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 338:1773-1774 June 11, 1998 Number 24
NextNext

Epoprostenol (Prostacyclin) Therapy in Primary Pulmonary Hypertension

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Barst, R. J.
-Related Article
 by McLaughlin, V. V.
-PubMed Citation
To the Editor: The study by McLaughlin et al. (Jan. 29 issue)1 implies that hypertensive pulmonary arteries develop beneficial structural changes after prolonged treatment with prostacyclin in patients with primary pulmonary hypertension. Since marked remodeling occurs throughout the vascular tree by the time severe pulmonary hypertension develops, structural changes could occur either proximally or distally. One might conjecture that more recent (i.e., less fibrotic and therefore potentially more reversible) remodeling is located proximally rather than in the distal vessels.

One wonders whether the clinical benefits of prostacyclin may be due primarily to altered hemodynamics, with secondary effects on pulmonary-artery structure, . . . [Full Text of this Article]

References




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.